Dung-Yang Lee

The anti–PD-1 antibody spartalizumab (S) in combination with dabrafenib (D) and trametinib (T) in previously untreated patients (pts) with advanced <i>BRAF</i> V600–mutant melanoma: Updated efficacy and safety from parts 1 and 2 of COMBI-i.

Georgina V. Long, Célèste Lebbé, Victoria Atkinson et al. · Journal of Clinical Oncology · 2019 · 36 citations

Medicine, Clinical Sciences, Oncology +17

Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial

Kevin Cannon, José F. Cardona, Kari Yacisin et al. · Vaccine · 2023 · 29 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults ≥65 years old

David Fitzpatrick, Mariano Young, Kari Yacisin et al. · Vaccine · 2023 · 27 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16